Claudia Maios
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Repurposing the HMG-CoA Reductase Inhibitor Atorvastatin for SRD5A3-CDG.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS.
Journal: Cell
Published: January 25, 2026
Characterization of a C9orf72 Knockout Danio rerio model for ALS and cross-species validation of potential therapeutics screened in Caenorhabditis elegans.
Journal: PloS one
Published: August 22, 2025
CHK1 inhibition rescues abnormal glycogen buildup in a Caenorhabditis elegans model for glycogen storage disease III.
Journal: Communications biology
Published: December 09, 2024
Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics.
Journal: Journal of experimental neurology
Published: January 01, 2024
Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.
Journal: American journal of human genetics
Published: December 08, 2023
Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.
Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.
Journal: Human molecular genetics
Published: January 06, 2022
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS.
Journal: Cell
Published: October 06, 2021
A single copy transgenic mutant FUS strain reproduces age-dependent ALS phenotypes in C. elegans.
Journal: microPublication biology
Published: August 03, 2021
Chemical and genetic rescue of in vivo progranulin-deficient lysosomal and autophagic defects.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 18, 2021
Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 08, 2021
Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 15, 2020
Last Updated: 09/26/2026